Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer

Overview of attention for article published in Frontiers in oncology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 13 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,440 followers.

New research: Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer: Although anti-PD-1 inhibitors exhibit impressive clinical results in non-small cell lung cancer (NSCLC) cases, a… https://t.co/hfyGXnz

28 Apr 2021

Reply Repost Favourite

New article: Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer https://t.co/Z14Rz42ftw #lungcancer #oncology https://t.co/FO1QtIdaoU

08 Apr 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.